Ethanol drinking and the basal ganglia circuitry
Ethanol drinking and the basal ganglia circuitry
批准号:
10507961
负责人:
Jun Wang
金额:
$33.5万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-06-15 至 2025-03-31
关键词:
AffectAgingAlcohol consumptionAlcoholsAlzheimer&aposs DiseaseAlzheimer&aposs disease modelAlzheimer&aposs disease patientAlzheimer&aposs disease related dementiaAreaBasal GangliaBehaviorCognitionCognitiveCognitive deficitsConsumptionCorpus striatum structureDataDiseaseFemaleGlutamatesGoalsHeavy DrinkingImpaired cognitionImpairmentInterneuronsKnowledgeMeasurementMeasuresMediatingMusNeuronsPathogenesisPathway interactionsPatientsPrevalenceRegulationReportingResearchResearch ProposalsReversal LearningRodent ModelRoleSliceTestingThalamic structureTransgenic MiceWaterWild Type MouseWomanalcohol abuse therapyalcohol effectalcohol exposurealcohol use disorderbasal forebraincholinergiccholinergic neuroncognitive developmentdrinkingdrinking waterearly onsetexperimental studyflexibilitygamma-Aminobutyric Acidhuman imagingimaging studyimprovedinnovationinsightmalemenmouse modelneglectneural circuitneurotransmissionnew therapeutic targetnovel strategiesnovel therapeutic interventionnovel therapeuticsoptogeneticsparent grantselective expressiontransmission process
中文摘要
拟议的研究是一个逻辑扩展的目的2和3的母基金,R 01 AA 027768-
02,这决定了“过量的乙醇摄入是否会损害丘脑对纹状体的调节,
胆碱能中间神经元(CIN)和CIN介导的直接通路中型棘神经元的调节
(dMSN),导致不灵活的行为。“这种扩展包括酒精引起的
胆碱能活性有助于阿尔茨海默病中认知缺陷的发生和发展,
相关性痴呆(ADRD),这进一步提高了我们对
酒精使用障碍叠加ADRD。因此,本研究与ADRD相关。
酒精使用障碍的特点是顽固的强迫性饮酒,尽管有负面影响。
类似的认知能力是阿尔茨海默病的一个标志。认知灵活性的缺陷,
疾病可能是由降低的胆碱能活性介导的。纹状体含有dMSN和CIN。
dMSN的活性会因过量的酒精摄入而增强。初步研究发现,dMSN发送GABA能
投射以抑制基底前脑中的纹状体CINs和胆碱能投射神经元(CPNs)。纹状体
CIN还从丘脑接收丘脑能输入。来自父母补助金的研究发现,
酒精摄入减少了丘脑对CIN的输入和CIN活性,损害了逆转学习的灵活性。是
目前尚不清楚酒精是如何调节阿尔茨海默病患者的胆碱能活动的。本研究
探讨过量饮酒如何降低5xFAD小鼠模型中的CIN和CPN活性
老年痴呆症假设是过量的酒精摄入加剧了
增强抑制性dMSN→CIN(或CPN)传递,并减少对CIN的神经递质性丘脑输入,
导致阿尔茨海默病的5xFAD小鼠模型中胆碱能活性降低。我们将测试这个
通过以下两个具体目标来验证这一假设:(1)测试过量乙醇摄入是否会增强dMSN→CIN
在5xFAD小鼠中比在野生型对照中更大程度地传递dMSN或dMSN→CPN;(2)确定
过量的乙醇摄入是否会在更大程度上降低DMS CIN中的丘脑纹状体传递,
5xFAD小鼠中比野生型对照中更高。这项研究在概念上是创新的,因为它侧重于
在这两种疾病中,纹状体介导的胆碱能机制相对被忽视的区域。是
在其组合使用三重转基因小鼠和光遗传学刺激以选择性地
测量三个神经回路,并确定它们对这两种疾病中胆碱能活性低下的贡献。
从这一提议中产生的知识将提供改善胆碱能活性的新策略,
认知灵活性,从而为酒精使用障碍和阿尔茨海默病的治疗提供信息。
英文摘要
The proposed research is a logical expansion of Aims 2 and 3 of the parent grant, R01AA027768-
02, which determines whether "excessive ethanol intake compromises thalamic regulation of striatal
cholinergic interneurons (CINs) and CIN-mediated regulation of direct-pathway medium spiny neurons
(dMSNs), leading to inflexible behaviors." This expansion includes how the alcohol-induced reduction of
cholinergic activity contributes to the onset and progression of cognitive deficit in Alzheimer's disease and
related dementias (ADRD), which further improve our understanding of the pathogenesis of
alcohol use disorder superimposed on ADRD. Therefore, this research is relevant to ADRD.
Alcohol use disorder is characterized by inflexible compulsive drinking, despite negative consequences.
Similar cognitive inflexibility is a hallmark of Alzheimer's disease. Deficits in cognitive flexibility in both
diseases are likely mediated by reduced cholinergic activity. The striatum contains dMSNs and CINs.
dMSN activity is enhanced by excessive alcohol intake. Preliminary studies found that dMSNs sent GABAergic
projections to inhibit striatal CINs and cholinergic projection neurons (CPNs) in the basal forebrain. Striatal
CINs also receive glutamatergic inputs from the thalamus. Studies from the parent grant found that excessive
alcohol intake reduces thalamic inputs to CINs and CIN activity, impairing flexibility in reversal learning. It is
not known how alcohol regulates cholinergic activity in the context of Alzheimer's disease. This research
explores how excessive alcohol intake reduces CIN and CPN activity in the 5xFAD mouse model
of Alzheimer's disease. The hypothesis is that excessive alcohol intake exacerbates the onset and extent of
enhanced inhibitory dMSN→CIN (or CPN) transmission and reduces glutamatergic thalamic inputs to CINs,
leading to hypocholinergic activity in the 5xFAD mouse model of Alzheimer's disease. We will test this
hypothesis via the following two specific aims: (1) Test whether excessive ethanol intake enhances dMSN→CIN
or dMSN→CPN transmission to a greater extent in 5xFAD mice than in wild-type controls; (2) Determine
whether excessive ethanol intake reduces thalamostriatal transmission in DMS CINs to a greater extent in
5xFAD mice than in wild-type controls. This research is conceptually innovative because it focuses on the
relatively neglected area of the striatum-mediated hypocholinergic mechanisms in both disorders. It is
technically innovative in its combined use of triple transgenic mice and optogenetic stimulation to selectively
measure three neural circuits and determine their contributions to hypocholinergic activity in both diseases.
Knowledge generated from this proposal will provide novel strategies for improving cholinergic activity and
cognitive flexibility, thereby informing the treatment of alcohol use disorder and Alzheimer's disease.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Striatal ensemble plasticity in alcohol use disorder
-
批准号:10734890
-
项目类别:
-
资助金额:$45.81万
-
财政年份:2023
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10457835
-
项目类别:
-
资助金额:$74.14万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
High-Resolution Spatial MIST Technology for Functional Proteomic Study of Neuroinflammation in Alzheimer's Disease
-
批准号:10343115
-
项目类别:
-
资助金额:$46.25万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Repurposing of Maraviroc for the treatment of neuropathic pain
-
批准号:10586296
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10364861
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
NanoDiagnotic Technology I-Corps Training
-
批准号:10541690
-
项目类别:
-
资助金额:$5.5万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10543633
-
项目类别:
-
资助金额:$39.27万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10693823
-
项目类别:
-
资助金额:$73.01万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Sex-specific role of CCL5/CCR5 axis in depression and its therapeutic implication
-
批准号:10653682
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2022
-
负责人:Jun Wang
-
依托单位:
Development of dual inhibitors targeting the viral main protease and the host cathepsin L as SARS-CoV-2 antivirals
-
批准号:10191875
-
项目类别:
-
资助金额:$27.83万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10443877
-
项目类别:
-
资助金额:$23.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Rapid detection of infectious viral particles by cluster induced exhaustive reaction
-
批准号:10282122
-
项目类别:
-
资助金额:$19.6万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Development of an integrated smartphone/resistive nanosensor for onsite biomonitoring of exposure to pesticides
-
批准号:10255622
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Single-Cell Functional Proteomics Study of Neurodegeneration in Alzheimer's Disease
-
批准号:10191268
-
项目类别:
-
资助金额:$43.86万
-
财政年份:2021
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10599264
-
项目类别:
-
资助金额:$33.33万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10513411
-
项目类别:
-
资助金额:$33.37万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Genetic dissection of Cardiac Conduction System homeostasis and regeneration
-
批准号:9740018
-
项目类别:
-
资助金额:$36.62万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Ethanol drinking and the basal ganglia circuitry
-
批准号:10190746
-
项目类别:
-
资助金额:$33.4万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10543627
-
项目类别:
-
资助金额:$54.06万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
Drug target validation of the enterovirus D68 2A protease
-
批准号:10454230
-
项目类别:
-
资助金额:$72.07万
-
财政年份:2020
-
负责人:Jun Wang
-
依托单位:
海外基金